test

Management Team

Carrolee Barlow, MD, PhD
Chief Executive Officer

Carrolee Barlow, MD, PhD—renowned expert in neuroscience and neurodegeneration—joined the Parkinson’s Institute and Clinical Center as Chief Executive Officer (CEO) in February 2014. Dr. Barlow is the second CEO in the Institute’s 25 year history. She takes the reins from Dr. J. William Langston, who founded the organization in 1988.

Dr. Barlow’s previous work has spanned clinical care, laboratory and clinical research, academia, and industry. She is the former Chief Scientific Officer and Chief Medical Officer of BrainCells, Inc. in San Diego, California, a biotechnology company focused on the discovery and development of small molecules that stimulate adult hippocampal neurogenesis for the treatment of neurological and psychiatric disease using human neural stem cell technology. Prior to BrainCells, she served as the Director of Molecular Neuroscience and Therapeutic Area Head for Stroke and Neurodegeneration at Merck Research Laboratories where she was responsible for neuroscience biology, global exploratory, licensing, and full-phase efforts. Dr. Barlow has held a faculty position in the Laboratory of Genetics at the Salk Institute for Biological Studies in La Jolla, California. She also serves as an advisory board member for several biotechnology companies and disease foundations advancing therapies for rare diseases and disorders of the central nervous system (CNS).

Dr. Barlow received her MD from the University of Utah, did her residency in Internal Medicine at The New York Hospital, Cornell Medical Center, and went on to obtain a PhD in molecular and developmental biology at the Karolinska Medical Nobel Institute in Stockholm, Sweden. Shortly thereafter, she joined the National Institutes of Health and completed medical sub-specialty training in the field of endocrinology and a postdoctoral fellowship in neurogenetics at the National Human Genome Research Institute.



Anthony Santiago, MD
Chief Medical Officer

Dr. Santiago is a nationally-recognized expert in neurodegenerative disorders and investigator for both industry-sponsored and publicly-funded research; author of
numerous peer reviewed journal articles and book chapters; frequent lecturer for patient
advocacy groups, industry partners in pharmacological and medical-device development, academic institutions and professional medical societies.

He is a highly-regarded and award-winning educator, recognized for his outstanding didactic and clinical teaching; his trainees have gone on to the some of the most coveted Fellowship and Faculty positions in Neurology in the US. He is a consummate diagnostician and clinician who emphasizes a holistic and humanistic approach to patient care, partnering with his patients and their families to create a relationship that is mutual and nurturing, but also values clinical accuracy and scientific rigor.

Dr. Santiago most recently served as the Chief Medical Officer and member of the Board of Directors for Pathways Group, Inc., a professional consortium of clinicians, data scientists,
educators, academic and industry translational researchers, professional athletes and community leaders dedicated to improving the lives of people with neurodegenerative disorders. He was responsible for the development, validation and integration of medical content for its telehealth platform designed to solve the challenges inherent to providing a virtual portal for specialized patient care and clinical trial performance.

Prior to Pathways Group, Inc., Dr. Santiago was Vice-Chair of the Department of Neurology at the University of Minnesota (UMN) School of Medicine, where he also served as the Chief of the Divisions of Movement Disorders and Ataxia; Director of the Neurology Residency Program; Director of the Movement Disorders / Neuromodulation Fellowship Program; and Administrative Core Director for the Udall Parkinson’s Disease Center of Excellence.

Prior to his arrival at the UMN, he was Associate Professor of Neurology and National Parkinson Foundation Center Director at the Muhammad Ali Parkinson Center of Barrow Neurological Institute – a designated National Center of Excellence in care delivery, education, research and community outreach. He also served as the Director for Clinical and Translational Research in Neurodegenerative Disorders and Director of the Movement Disorders / Neuromodulation Fellowship Program.

 

Dr. Santiago is an Alpha Omega Alpha graduate of the Albany Medical College in Albany, NY – where he also completed his post-graduate training in Neurology, a Fellowship in Movement Disorders / Neuromodulation, and was an Assistant Professor in the Neurology Department. He is a Summa Cum Laude graduate of Le Moyne College, where he received his Bachelor of Science in Psychology and Chemistry.

 



Joy Chesbrough
Chief Development Officer

Joy joined the Parkinson’s Institute and Clinical Center in November of 2017. Her passion for philanthropy and nonprofit leadership is evident in the way she approaches fundraising and donor relationships.

Joy is a talented nonprofit leader and communicator who has been published in various magazines, including San Diego Magazine. She has been a panel speaker and presented on philanthropy and co-created corporate partnerships and shared value at Scripps 4th & 5th Annual Natural Supplement conference, Scripps Center for Integrative Medicine Health conference, The American Board of Integrative Holistic Medicine conference in San Diego and in 2012 at the Phoenix Business Journal’s 2012 Corporate Partnership Summit. 

Professionally, Joy has spent 20 years as an executive nonprofit leader managing nonprofit organizations and teams. Joy holds an M.A in Communication from Regent’s School of Cinematography and an M.A. in Nonprofit Leadership and Management from the University of San Diego’s, Caster School of Nonprofit Leadership. 

Prior to running her own consulting firm, Philanthrovation, Joy focused on digital communication, grant writing, nonprofit major gift fundraising and strategic planning. She served in a senior executive role for MAP International, voted as one of CNN and Forbes top charities, and as a Senior Director at World Vision where she was part of a national fundraising team that launched the For Every Child campaign that raised $500 million to reach 10 million children worldwide. Moreover, Joy was the executive development director that worked with Scripps Health Foundation to raise investments for a premier Integrative Medicine Clinic and Center in La Jolla, California. And, as Petsmart Charities National Director of Philanthropy, she managed a philanthropy department and was part of an executive team that launched Petsmart’s first national cause-marketing campaign called, People Saving Pets where she raised over $100 million in investments. Joy’s spent the last ten years as a member of the Association for Fundraising Professionals (AFP) where she served on the board for two years as their Chair of Corporate Partnerships.

Joy is a distinguished member of Worldwide Who’s Who International and was recently awarded, Professional of the Year by the agency in 2013. 



675 Almanor Avenue | Sunnyvale, CA 94085
408.734.2800 main | 408.734.8455 fax (Main) | 408.734.9208 fax (Clinic Secure)